Alibaba Health Information Technology Limited (HKG:0241)

Market Cap	45.50B -57.6%
Revenue (ttm)	38.94B +12.0%
Net Income	2.20B +35.2%
EPS	0.14 +34.6%
Shares Out	16.16B
PE Ratio	20.72
Forward PE	19.11
Dividend	0.07 (2.47%)
Ex-Dividend Date	Aug 12, 2026

Volume	39,195,348
Open	2.850
Previous Close	2.865
Day's Range	2.795 - 2.850
52-Week Range	2.745 - 7.910
Beta	1.58
Analysts	Buy
Price Target	4.59 (+63.06%)
Est. Earnings	Nov 25, 2026

About HKG:0241

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People’s Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,394
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0241

Financial Performance

In fiscal year 2026, HKG:0241's revenue was 34.26 billion, an increase of 11.95% compared to the previous year's 30.60 billion. Earnings were 1.94 billion, an increase of 35.17%.

Financial numbers in CNY

Analyst Summary

According to 15 analysts, the average rating for 0241 stock is "Buy." The 12-month stock price target is $4.59, which is an increase of 63.06% from the latest price.

Price Target

$4.59

(63.06% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 2, 2026

Data Sources Report a data error